Filter
7857
Filtered Results: 7857
Text search:
drugs
act
Featured
Recommendations
658
New Publications
2027
Language
Document type
No document type
4750
Studies & Reports
1135
Guidelines
980
Manuals
342
Strategic & Response Plan
229
Fact sheets
169
Training Material
131
Situation Updates
39
Infographics
31
Brochures
22
Resource Platforms
17
Online Courses
8
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
467
Global
239
Kenya
229
South Africa
181
Uganda
162
Ethiopia
162
Nigeria
154
Western and Central Europe
154
Nepal
142
Sierra Leone
140
Liberia
122
Zambia
117
Malawi
113
Tanzania
113
Latin America and the Carribbean
109
Ghana
103
Africa
100
Bangladesh
98
Rwanda
97
Myanmar / Burma
95
Ukraine
87
Eastern Europe
75
Namibia
66
Philippines
65
Zimbabwe
57
Congo, Democratic Republic of
57
Russia
54
Indonesia
51
Senegal
50
Asia
50
South–East Asia Region
50
Syria
48
Cambodia
46
Lesotho
43
Burkina Faso
43
Mozambique
39
Germany
37
South Sudan
37
Botswana
35
Colombia
32
Brazil
30
Eswatini/ Swaziland
29
Haiti
26
Venezuela
26
West and Central Africa
26
Middle East and North Africa
24
East and Southern Africa
24
Cameroon
23
Guinea
21
Tajikistan
20
Benin
19
Peru
19
Eastern Europe and Central Asia
19
Paraguay
19
Argentina
19
Yemen
18
Chile
16
USA
16
Sudan
16
Afghanistan
15
Pakistan
15
Albania
14
Vietnam
13
Bolivia
12
Moldova
12
Georgia
12
Central African Republic
12
Thailand
11
Lebanon
11
Somalia
11
Madagascar
11
Laos
10
Mali
10
China
9
Armenia
9
Western Pacific Region
9
North Macedonia
8
Mexico
8
Ecuador
8
El Salvador
7
Sri Lanka
7
Niger
6
Jordan
6
North America
6
United Kingdom
6
Southern Africa
6
Palestine
6
Iraq
6
Turkey
5
Angola
5
Libya
5
Bhutan
5
Iran
4
Fiji
4
Kyrgyzstan
4
Uzbekistan
4
Burundi
4
Guinea-Bissau
4
Saudi Arabia
4
Jamaica
4
Spain
4
Côte d’Ivoire / Ivory Coast
4
Papua New Guinea
4
Egypt
4
Romania
4
Poland
4
Chad
4
Timor Leste/ East Timor
3
Serbia
3
Gambia
3
Kazakhstan
3
Morocco
3
Uruguay
3
Belarus
3
Djibouti
3
Greece
3
Canada
2
Singapore
2
Estonia
2
Mongolia
2
Qatar
2
Hungary
2
Lithuania
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Mauritius
2
Tunisia
2
Portugal
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Congo-Brazzaville
1
Bulgaria
1
Mauritania
1
Italy
1
Dominican Republic
1
Ireland
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3053
Clinical Guidelines
674
Public Health
377
Women & Child Health
333
Key Resources
190
Capacity Building
133
Pharmacy & Technologies
85
Annual Report MEDBOX
2
Toolboxes
HIV
851
Mental Health
780
TB
667
COVID-19
446
AMR
341
Pharmacy
241
NTDs
216
Caregiver
181
NCDs
167
Rapid Response
148
Ebola
142
Conflict
122
Refugee
121
Planetary Health
121
Disability
116
Global Health Education
82
Natural Hazards
57
Health Financing Toolbox
57
Zika
36
Cholera
30
Specific Hazards
29
Polio
27
Social Ethics
25
South Sudan
2
Health Financing
1
El Ministerio de Salud de Chile, atendida la relevancia de los medicamentos dentro del sistema de salud público y privado, ha planteado en la Política Nacional de Medicamentos (Res. Ex. MINSAL Nº 512/2004) los lineamientos y directrices bajo las cuales se deberá desarrollar la actividad nacional...
El documento que se presenta, aborda la Prescripción desde su esencia como un proceso racional y metódico, que basándose en los antecedentes diagnósticos pertinentes, permite la mejor elección posible de los medicamentos requeridos por el paciente. Asimismo, se han incorporado algunos anteceden...
El documento que se presenta, aborda el Uso Racional de Medicamento, así como aquellos conceptos que son requeridos para su apropiado establecimiento; y está destinado al personal técnico de salud, quienes realizan una importante labor complementando la acción de salud y en muchas ocasiones culm...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the actors, tim...
This Medical Product Alert relates to the recent circulation of two confirmed falsified versions of Quinine
Sulphate circulating in Cameroon and the Democratic Republic of the Congo, containing zero active
pharmaceutical ingredient
Cette Alerte fait référence à la circulation au Cameroun et en République Démocratique du Congo, de
deux versions falsifiées confirmées de Quinine Sulfate, qui ne contiennent aucun principe actif.
For the Fiscal Year 2015-2016, the Health Sector continued to implement actions meant to improve the availability, and access to quality healthcare. The following report highlights achievements registered by the health sector for the fiscal 2015-2016 in different health programs, as well as in the a...
The following checklist is a companion to Core Elements of Hospital Antibiotic Stewardship Programs. This checklist should be used to systematically assess key elements and actions to ensure optimal antibiotic prescribing and limit overuse and misuse of antibiotics in hospitals. CDC recommends that ...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...
2nd Generation HIV Surveillance in Pakistan, Round 5
The Overall objective of this mapping study was to update population size estimates of selected key populations (PWID, FSWs, MSM & TGs) to create evidence for developing action plans for HIV prevention interventions in Pakistan. A total numbe...
The Overall objective of this mapping study was to update population size estimates of selected key populations (PWID, FSWs, MSM & TGs) to create evidence for developing action plans for HIV prevention interventions in Pakistan. A total numbe...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la prévention et le traitement ...
La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situaciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mu...
The article "Can we prevent cardiovascular diseases in low- and middle-income countries?" by Claude Lenfant discusses the growing threat of cardiovascular diseases (CVDs) in developing countries. It highlights that while CVD is already the leading cause of death globally, low- and middle-income coun...
